LYST-AS1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, LYST-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LYST-AS1 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LYST-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LYST-AS1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LAML show a favorable association.

HNSC, LAML, and LUSC are the cancer types where LYST-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSMedianII,III,IV0.7460.635.00352view →
LAMLDFSMedianAll0.7370.409.00136view →
LUSCDFSTertileIII,IV0.1970.865<.00136view →
KICHDFSQuartileIII,IV0.0520.908<.00133view →
STADOSMedianII,III,IV0.4920.341.00632view →
UVMDFSTertileIII,IV0.2820.600.02018view →
THCAOSTertileII,III,IV0.6660.965.00517view →
KIRCOSTertileAll0.5720.701.02114view →
COADDFSTertileII,III,IV0.8030.634.0299view →
MESOOSTertileIII,IV0.1950.582.0349view →
LGGOSQuartileAll0.7120.854.0109view →
KIRPOSTertileAll0.9030.959.0296view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LYST-AS1–HNSC (DFS)

Kaplan–Meier survival curve for LYST-AS1 RNA-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration